ETON Eton Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ETON

Price (delayed)

$3.71

Market cap

$95.3M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.04

Enterprise value

$79.32M

Eton Pharmaceuticals, Inc. is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The company currently owns or receives royalties from three FDA-approved products, including ALKINDI® ...

Highlights
The debt has declined by 17% year-on-year and by 7% since the previous quarter
The company's net income has shrunk by 142% QoQ but it has surged by 90% YoY
ETON's EPS has dropped by 140% since the previous quarter but it has surged by 89% year-on-year
The quick ratio has contracted by 46% YoY and by 38% from the previous quarter
The gross margin has contracted by 7% from the previous quarter and by 3% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://etonpharma.com
Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of ETON
Market
Shares outstanding
25.69M
Market cap
$95.3M
Enterprise value
$79.32M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.15
Price to sales (P/S)
2.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.43
Earnings
Revenue
$32.64M
EBIT
-$1.19M
EBITDA
-$291,000
Free cash flow
$6.82M
Per share
EPS
-$0.04
Free cash flow per share
$0.27
Book value per share
$0.6
Revenue per share
$1.27
TBVPS
$1.05
Balance sheet
Total assets
$31.74M
Total liabilities
$16.26M
Debt
$5.4M
Equity
$15.48M
Working capital
$10.6M
Liquidity
Debt to equity
0.35
Current ratio
1.65
Quick ratio
1.53
Net debt/EBITDA
54.93
Margins
EBITDA margin
-0.9%
Gross margin
67.6%
Net margin
-2.9%
Operating margin
-0.6%
Efficiency
Return on assets
-3.2%
Return on equity
-6.2%
Return on invested capital
-747.3%
Return on capital employed
-7.7%
Return on sales
-3.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ETON stock price

How has the Eton Pharmaceuticals stock price performed over time
Intraday
-1.07%
1 week
7.54%
1 month
3.06%
1 year
-0.54%
YTD
-15.3%
QTD
-1.07%

Financial performance

How have Eton Pharmaceuticals's revenue and profit performed over time
Revenue
$32.64M
Gross profit
$22.06M
Operating income
-$192,000
Net income
-$936,000
Gross margin
67.6%
Net margin
-2.9%
The net margin has dropped by 143% since the previous quarter but it has surged by 93% year-on-year
The company's net income has shrunk by 142% QoQ but it has surged by 90% YoY
The operating income has plunged by 108% from the previous quarter but it has soared by 97% YoY
The company's operating margin has shrunk by 108% QoQ but it has surged by 98% YoY

Growth

What is Eton Pharmaceuticals's growth rate over time

Valuation

What is Eton Pharmaceuticals stock price valuation
P/E
N/A
P/B
6.15
P/S
2.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.43
ETON's EPS has dropped by 140% since the previous quarter but it has surged by 89% year-on-year
The stock's price to book (P/B) is 56% less than its 5-year quarterly average of 13.9 and 11% less than its last 4 quarters average of 6.9
ETON's equity is up by 18% year-on-year but it is down by 8% since the previous quarter
ETON's P/S is 99% below its 5-year quarterly average of 306.1 and 14% below its last 4 quarters average of 3.4
The revenue is up by 43% YoY but it is down by 2.5% QoQ

Efficiency

How efficient is Eton Pharmaceuticals business performance
ETON's return on sales has dropped by 146% since the previous quarter but it has surged by 90% year-on-year
The return on assets has dropped by 140% since the previous quarter but it has surged by 92% year-on-year
Eton Pharmaceuticals's ROE has plunged by 140% from the previous quarter but it has soared by 91% YoY

Dividends

What is ETON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ETON.

Financial health

How did Eton Pharmaceuticals financials performed over time
ETON's total assets is 95% more than its total liabilities
Eton Pharmaceuticals's current ratio has decreased by 47% YoY and by 37% from the previous quarter
The quick ratio has contracted by 46% YoY and by 38% from the previous quarter
The debt is 65% smaller than the equity
ETON's debt to equity is down by 30% year-on-year but it is up by 2.9% since the previous quarter
ETON's equity is up by 18% year-on-year but it is down by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.